文章摘要
鲁锐,瞿云昆,杨卿,等.酸浆苦味A通过抗炎和抗凋亡途径延缓骨关节炎的进展.骨科,2022,13(5): 426-432.
酸浆苦味A通过抗炎和抗凋亡途径延缓骨关节炎的进展
Physalin A Delays the Progression of Osteoarthritis through Anti-inflammatory and Anti-apoptotic Pathways
投稿时间:2022-05-04  
DOI:10.3969/j.issn.1674-8573.2022.05.009
中文关键词: 酸浆苦味A  骨关节炎  软骨细胞  抗炎  凋亡
英文关键词: Physalin A  Osteoarthritis  Chondrocyte  Anti-inflammatory  Apoptosis
基金项目:国家自然科学基金(81601951)
作者单位E-mail
鲁锐 华中科技大学同济医学院附属同济医院骨科武汉 430030  
瞿云昆 华中科技大学同济医学院附属同济医院骨科武汉 430030  
杨卿 华中科技大学同济医学院附属同济医院骨科武汉 430030  
何琰泽 随州职业技术学院医学院湖北随州 441300  
梁爽 华中科技大学同济医学院附属同济医院骨科武汉 430030 liangshuang0310@163.com 
摘要点击次数: 2228
全文下载次数: 1462
中文摘要:
      目的 探究酸浆苦味A(Physalin A,PA)对骨关节炎的保护作用及作用机制。方法 取5日龄的C57BL/6乳鼠膝关节原代软骨细胞进行传代培养,使用5 ng/mL的白细胞介素-1β(IL-1β)刺激原代软骨细胞以模拟骨关节炎的软骨细胞炎性模型,并使用不同浓度的PA(2.5 μmol/L、5 μmol/L、10 μmol/L)进行干预,具体分组为对照组、IL-1β组、IL-1β+PA(2.5 μmol/L)组、IL-1β+PA(5 μmol/L)组、IL-1β+PA(10 μmol/L)组。Western blot法检测不同组间蛋白聚糖(ACAN)、二型胶原(COL2A1)、基质金属蛋白酶13(MMP13)、Ⅰ型血小板结合蛋白基序的解聚蛋白样金属蛋白酶(ADAMTS5)、诱导型一氧化氮合酶(iNOS)、环氧合酶2(COX-2)、白细胞介素6(IL-6)和B淋巴细胞瘤-2(Bcl-2)、Bcl-2相关X蛋白(Bax)的表达水平。结果 与对照组比较,IL-1β组ACAN、COL2A1蛋白表达水平明显下调(P<0.05),而MMP13、ADAMTS5和iNOS、COX-2、IL-6蛋白表达水平显著升高(P<0.05);相比于IL-1β组,IL-1β+PA(2.5 μmol/L)组、IL-1β+PA(5 μmol/L)组、IL-1β+PA(10 μmol/L)组中ACAN、COL2A1蛋白表达水平逐渐升高(P<0.05),MMP13、ADAMTS5蛋白和iNOS、COX-2、IL-6蛋白表达水平逐渐下降(P<0.05)。此外,相比于对照组,IL-1β组Bcl-2/Bax比值下降(P<0.05);相比于IL-1β组,IL-1β+PA(2.5 μmol/L)组、IL-1β+PA(5 μmol/L)组、IL-1β+PA(10 μmol/L)组中,Bcl-2/Bax比值升高(P<0.05)。结论 PA能通过抗炎和抗凋亡途径发挥保护关节软骨的作用。
英文摘要:
      Objective To investigate the protective effect and mechanism of Physalin A on osteoarthritis. Methods The effects of PA on chondrocytes were studied in vitro. Primary chondrocytes were isolated from the knee joints of 5-day-old C57BL/6 neonatal mice. The cells were stimulated with 5 ng/mL interleukin-1β (IL-1β) to mimic the chondrocyte inflammatory model of osteoarthritis, along with the administration of different concentrations of PA (2.5, 5 and 10 μmol/L), serving as the control group, the IL-1β group, the IL-1β+PA (2.5 μmol/L) group, the IL-1β+PA (5 μmol/L) group, and the IL-1β+PA (10 μmol/L) group, respectively. Western blotting was used to detect the expression levels of ACAN, COL2A1, MMP13, ADAMTS5, iNOS, COX-2, IL-6, Bcl-2 and Bax of chondrocytes among different intervention groups. Results Compared with the control group, the expression levels of ACAN and COL2A1 in chondrocytes in the IL-1β group were significantly down-regulated (P<0.05), and the expression levels of MMP13, ADAMTS5, iNOS, COX-2 and IL-6 were significantly up-regulated (P<0.05). As compared with the IL-1β group, the ACAN and COL2A1 were increased, and the MMP13, ADAMTS5, iNOS, COX-2, IL-6 were decreased in the IL-1β+PA (2.5 μmol/L) group, IL-1β+PA (5 μmol/L) group, and the IL-1β+PA (10 μmol/L) group (P<0.05). In addition, compared with the control group, the Bcl-2/Bax ratio in chondrocytes in the IL-1β group decreased (P<0.05). As compared with IL-1β group, the Bcl-2/Bax ratio was increased in the IL-1β+PA (2.5 μmol/L) group, IL-1β+PA (5 μmol/L) group, and the IL-1β+PA (10 μmol/L) group (P<0.05). Conclusion PA protects articular cartilage through anti-inflammatory and anti-apoptotic pathways.
查看全文   下载PDF阅读器
关闭